Cardiopulmonary Complication in Aneurysmal Subarachnoid Haemorrhage Patients
Launched by KUOPIO UNIVERSITY HOSPITAL · Aug 21, 2012
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
Laboratory markers daily: Routine laboratory test (blood gases, haemoglobin, thrombocytes, leukocytes, INR, bilirubin, creatinine, c-reactive protein, CK, CK-MB, Tnt, BNP, sodium, potassium, magnesium) are taken at 8 a.m. Study laboratory tests (sensitive ischemia markers, remodelling marker MMP-9 and CgA as surrogate marker for increased sympathetic activity) are taken four times during study period at the same time as cardiac ECHOes and Holtering. Gene sample is taken once on day one.
Primary outcome measurement is to document the incidence of myocardial dysfunction and the predictive fa...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with nontraumatic subarachnoid haemorrhage
- • Age \> 18 years
- • Aneurysmal bleeding
- Exclusion Criteria:
- • No consent
- • Age \< 18 years
- • Anticipated brain death \< 24 hours
- • Otherwise moribund patient
About Kuopio University Hospital
Kuopio University Hospital is a leading academic medical center located in Finland, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient-centered care, focusing on diverse therapeutic areas. With a commitment to enhancing treatment outcomes and improving patient quality of life, Kuopio University Hospital fosters collaboration among multidisciplinary teams, leveraging its robust infrastructure and expertise to drive medical progress and translate research findings into practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bern, , Switzerland
Turku, , Finland
Kuopio, , Finland
Patients applied
Trial Officials
Stepani Bendel, PhD, MD
Study Director
Senior consultant, intensivist
Maarit Lång, MD
Principal Investigator
Senior consultant, intensivist
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials